FK506-binding protein 11, a novel plasma cell specific antibody folding catalyst, is increased in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
Cloning, expression and purification of a recombinant lipid transfer protein and an αβ-gliadin from wheat: determination of the diagnostic impact by specific IgE-measurements Source: Annual Congress 2009 - Old and new topics in environmental and occupational lung disease Year: 2009
BR22, a 26 kDa thyroid transcription factor-1 associated protein (TAP26), is expressed in human lung cells Source: Eur Respir J 2003; 22: 28-34 Year: 2003
Major basic protein localization in human airway following in vitro eosinophil incubation Source: Eur Respir J 2002; 20: Suppl. 38, 94s Year: 2002
Activated protein phosphatase PP2A by formoterol enhances nuclear translocation of glucocorticoid receptor induced by budesonide Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011
Characterization of the activity of the different oligomeric forms of pulmonary human surfactant protein SP-D Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
Corticosteroid lipophilicity is a more important determinant of corticosteroid uptake into human hepatocytes than serum protein binding Source: Eur Respir J 2007; 30: Suppl. 51, 351s Year: 2007
Loss of structural integrity and function of surfactant protein D (SP-D) by cystic fibrosis- related proteases Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001
Ultrastructure of the pulmonary surfactant and its alterations after general inhibition of protein synthesis in the rat Source: Eur Respir J 2002; 20: Suppl. 38, 374s Year: 2002
Increased expression of Lysosomal-associated membrane protein 1 (LAMP-1) found in small airway epithelium of COPD may have functional consequence and role in autophagy. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017
Activation and localization of transcription factor, nuclear factor-κB (NF-κB), in bronchiectasis in vivo Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001
Visualization of apoptosis-related proteins in lung treated with recombinant human active protein C in sepsis model Source: Eur Respir J 2005; 26: Suppl. 49, 221s Year: 2005
The RNA binding protein HuR regulates the senescence-associated secretory phenotype under conditions of oxidative stress Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019
The impact of a high fine particle fraction inhaled long acting ß2 agonist (Formoterol) on airway function in asthma: evaluation with oxygen enhanced MRI and multiple breath washout. Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017
How does smoking influence major phospholipids and proteins in lung surfactant? Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
Use of steroid receptor related STIP1 gene analysis as an asthma marker Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012
Low expression of cellular retinoic acid binding protein 2 and dysregulation of elastin expression in pulmonary emphysema fibroblasts Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008
The effect of montelukast added to steroid on airway function as compared with steroid alone and placebo: a single blind, controlled study in acute asthma Source: Eur Respir J 2001; 18: Suppl. 33, 263s Year: 2001
Importin-7 knockdown reduces corticosteroid induced glucocorticoid receptor nuclear localisation and suppression of IL-1beta induced CXCL8 Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013